Stanford scientists discovered that a harmless skin bacterium triggers a powerful immune response. By tweaking a bacterial ...

To compare EI with needle injection through these conventional routes, we used a formalin-inactivated Aichi/68 influenza virus to immunize BALB/c mice (n = 8 per group). For EI, the vaccine was ...

Nasal vaccine devices have the potential to offer more convenient and more effective protection against a variety of viruses.

No hospitals, no needles, no pain, only gain. “This provides a new option for receiving a safe and effective seasonal influenza vaccine potentially with greater convenience, flexibility and ...

A needle-free injection is a method of delivering medication into the body without using a needle Read this article to learn ...

Scientists at Stanford are developing a painless, topical vaccine using a common skin bacterium to trigger immunity.

Vaxxas, a clinical-stage biotechnology company, today announced the appointments of three globally respected vaccine experts as advisors to its product development and strategy team as the company ...

Vaxxas’ proprietary HD-MAP offers the potential for needle-free vaccination, reduction of refrigerated storage, and self-administration, making it less expensive, more effective and easier to ...

Vaxxas’ proprietary high-density microarray patch (HD-MAP) technology is currently being evaluated in a phase 1 clinical study of the first needle-free COVID-19 vaccine, having demonstrated ...